Literature DB >> 16950018

Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.

Ann N Burchell1, Rachel L Winer, Silvia de Sanjosé, Eduardo L Franco.   

Abstract

This chapter provides an overview of the epidemiology of human papillomavirus (HPV) infection, with a focus on the dynamics of sexual transmission. We explore concepts related to the spread of sexually transmitted infections, including population prevalence, duration of infectivity, patterns of sexual contacts, and transmissibility, including modifiers of susceptibility and infectivity. HPV prevalence and incidence are high in most studies, particularly amongst young women. There is strong evidence that transmission occurs primarily via sexual activity, most commonly vaginal and anal intercourse. Although the duration of infectivity may be short, current evidence suggests that HPV is highly transmissible. The implications of transmission dynamics for the success of future HPV vaccines are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16950018     DOI: 10.1016/j.vaccine.2006.05.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  135 in total

1.  Oral vs. Vaginal Sex Experiences and Consequences Among First-Year College Students.

Authors:  Eva S Lefkowitz; Sara A Vasilenko; Chelom E Leavitt
Journal:  Arch Sex Behav       Date:  2015-11-23

Review 2.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

Review 3.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

Review 4.  Human papillomavirus vaccines launch a new era in cervical cancer prevention.

Authors:  Meenakshi Dawar; Shelley Deeks; Simon Dobson
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

5.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

6.  Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection.

Authors:  Ali Rowhani-Rahbar; James P Hughes; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

7.  Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.

Authors:  Ann Nielsen; Thomas Iftner; Christian Munk; Susanne K Kjaer
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

8.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

Review 9.  Factors influencing familial decision-making regarding human papillomavirus vaccination.

Authors:  Heather L Gamble; James L Klosky; Gilbert R Parra; Mary E Randolph
Journal:  J Pediatr Psychol       Date:  2009-12-04

10.  Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Shu-Kuang Lee; Sandra F O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.